President Trump Just Announced Terrible News for Eli Lilly Investors
President Donald Trump’s second term in office has been challenging for investors, at least so far. Trump imposed sweeping tariffs on imports from most countries worldwide. For now, several industries have escaped these trade policies, including pharmaceuticals. However, recent developments suggest that it won’t last much longer. That could be bad news for leaders in […]
Journal Article – Implantable Drug Delivery Systems for GLP-1s Receptor Agonists. No more shots! What could go wrong?
Several companies and research groups are actively exploring implantable drug delivery systems for GLP-1 receptor agonists (GLP-1 RAs), aiming to improve patient adherence, convenience, and therapeutic outcomes. Here’s a summary of key players and motivations: Getting drugs into a human body is harder than it looks. The GLP1 need to be in the blood to […]
GPs demand tougher regulation of online prescribing of weight loss drugs
UK regulators must produce clear guidelines for the prescribing and monitoring of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss, particularly when treatment is initiated online, GP leaders have urged.Representatives at the annual UK conference of local medical committees (LMCs) in Glasgow passed a motion calling for the BMA’s General Practitioners Committee UK to push […]
Watch: Can drugs like Ozempic solve the obesity problem in India?
Watch as experts from healthcare industry investigate the popularity of GLP-1 drugs
GLP-1 RA medications found to be safe and effective for treating obesity in adults with mental illness
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on mood, well-being, and quality of life in those both with and without mental illness, according to a systematic review of the available evidence being presented […]
People on Ozempic start disliking meat and fried foods. We’re starting to learn why.
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why